Gelonghui, May 8 | According to the latest equity disclosure data from the Stock Exchange, on April 30, 2024, Sinopharm Holdings (01099.HK) obtained JPMorgan Chase & Co. increased its position by 1.37,000 shares at an average price of HK$20.0142 per share, involving approximately HK$26.559 million.
After the increase in holdings, JPMorgan Chase & Co.'s latest number of positions was 81.0281 million shares, and the holding ratio increased from 5.93% to 6.03%.
